Amedisys Income from Continuous Operations 2010-2024 | AMED

Amedisys income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Amedisys Annual Income from Continuous Operations
(Millions of US $)
2023 $-11
2022 $118
2021 $210
2020 $185
2019 $128
2018 $120
2017 $31
2016 $38
2015 $-2
2014 $13
2013 $-95
2012 $-95
2011 $-374
2010 $124
2009 $140
Amedisys Quarterly Income from Continuous Operations
(Millions of US $)
2024-09-30 $17
2024-06-30 $33
2024-03-31 $15
2023-12-31 $19
2023-09-30 $26
2023-06-30 $-80
2023-03-31 $25
2022-12-31 $32
2022-09-30 $25
2022-06-30 $29
2022-03-31 $32
2021-12-31 $34
2021-09-30 $45
2021-06-30 $81
2021-03-31 $50
2020-12-31 $46
2020-09-30 $72
2020-06-30 $35
2020-03-31 $32
2019-12-31 $28
2019-09-30 $34
2019-06-30 $34
2019-03-31 $32
2018-12-31 $28
2018-09-30 $32
2018-06-30 $34
2018-03-31 $27
2017-12-31 $-4
2017-09-30 $15
2017-06-30 $5
2017-03-31 $15
2016-12-31 $9
2016-09-30 $12
2016-06-30 $11
2016-03-31 $6
2015-12-31 $13
2015-09-30 $9
2015-06-30 $11
2015-03-31 $-35
2014-12-31 $9
2014-09-30 $9
2014-06-30 $8
2014-03-31 $-12
2013-12-31 $-9
2013-09-30 $-91
2013-06-30 $2
2013-03-31 $3
2012-12-31 $-120
2012-09-30 $10
2012-06-30 $8
2012-03-31 $7
2011-12-31 $8
2011-09-30 $-422
2011-06-30 $23
2011-03-31 $17
2010-12-31 $33
2010-09-30 $22
2010-06-30 $32
2010-03-31 $37
2009-12-31 $42
2009-09-30 $36
2009-06-30 $35
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.744B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00